The Neurology Minute podcast delivers a brief daily summary of what you need to know in the field of neurology, the latest science focused on the brain, and timely topics explored by leading neurologists and neuroscientists. From the American Academy of Neurology and hosted by Stacey Clardy, MD, PhD…
The Neurology Minute podcast is an incredible resource for anyone interested in neurology or seeking to expand their knowledge on the subject. Hosted by Dr. Stacey Clardy, the show excels at taking complex subjects and breaking them down in a way that is understandable to the average person. With episodes lasting just a minute or two, it's an easy listen that can truly change the way one speaks to a patient or even make a diagnosis.
One of the best aspects of The Neurology Minute podcast is its brevity combined with its informative and targeted content backed up by evidence-based science. Each episode provides concise information that is relevant and practical. The guests interviewed on this show are experts in their field, and their insights can have a direct impact on the care of patients. The interviews are thought-provoking and often provide unique perspectives not commonly found elsewhere.
Despite its many strengths, one possible drawback of The Neurology Minute podcast is its short format. While it is great for those who prefer quick learning bites or have limited time available, it may not delve as deeply into certain topics as some listeners would like. However, given that each episode lasts only a minute or two, it still manages to cover a surprising amount of information.
In conclusion, The Neurology Minute podcast is a must-listen for anyone interested in neurology or looking to enhance their medical knowledge. It offers concise yet impactful episodes that provide valuable insights from experts in the field. Whether you're a medical student considering neurology as a specialty or simply looking to broaden your understanding of neurological conditions, this podcast delivers high-quality content in bite-sized portions. Don't miss out on this opportunity to learn from some of the best minds in neurology!
In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Tilly Edinger.
In the August episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss the mid-year assessment of AAN's five-year strategic plan. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight
In the third episode of this series, Dr. Andy Southerland discusses the latest Capitol Hill Report, which outlines the 2026 Medicare fee schedule proposal. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Dr. Kathryn Krulisky and Dr. Jordan Garris discuss educational gaps in understanding FND, the impact of stigma on patient care, and the importance of empathy in medical training. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200219
Dr. Shuvro Roy and Dr. Daniel Blockmans discuss the efficacy and safety of upadacitinib as a treatment option for giant-cell arteritis. Show reference: https://www.nejm.org/doi/10.1056/NEJMoa2413449
In part eight of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the study findings and the potential impact on clinical practice. Show reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2824325
In part seven of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss how to counsel patients about getting care abroad. Show reference: https://academic.oup.com/cid/article/78/6/1554/7280488
In part six of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss findings from a recent systematic review on pneumococcal meningitis, including the role of corticosteroid, the importance of treatment timing, and emerging adjunctive therapies that may improve patient outcomes. Show reference: https://academic.oup.com/braincomms/article/6/3/fcae131/7644484
Dr. Jason Crowell discusses clinical considerations when addressing cognitive concerns in patients with Parkinson disease. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209699 https://directory.libsyn.com/episode/index/id/32642512
Dr. Dan Ackerman and Dr. James Ernest Siegler discuss the complexities of treating ESUS and emphasize the importance of personalized treatment approaches based on individual patient factors. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213876
In part five of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the study findings and when clinicians should maintain suspicion for parechovirus. Show reference: https://academic.oup.com/cid/article-abstract/79/6/1479/7726317?redirectedFrom=fulltext
In the second episode of this two-part series, Dr. Justin Abbatemarco and Dr. Eric L. Voorn discuss how to integrate these coaching elements into practice to promote sustainable changes. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213781 https://www.sciencedirect.com/science/article/pii/S0960896625000458?via%3Dihub
In the second episode of this series, Dr. Andy Southerland discusses the latest Capitol Hill Report, breaking down what a reconciliation bill is and why it matters. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Dr. Trey Bateman and Dr. Gregg Day discuss the study design, findings, and clinical implications of using plasma biomarkers in real-world patient care. Show reference: https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/alz.70316
In part one of this two-part series, Dr. Justin Abbatemarco and Dr. Eric L. Voorn discuss how exercise remains essential for people with neuromuscular disorders, even amid limited pharmaceutical options and safety concerns. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213781 https://www.sciencedirect.com/science/article/pii/S0960896625000458?via%3Dihub
In part four of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss enterovirus D68 and the findings presented in this article. Show reference: https://pubmed.ncbi.nlm.nih.gov/39564148/
In part three of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss when to suspect Oropouche virus and how to test for it. Show reference: https://onlinelibrary.wiley.com/doi/10.1002/ana.27139
In the second episode of this two-part series, Dr. Jeff Ratliff and Dr. Claire Henchcliffe discuss how she advises patients and families on the future of stem cell therapy and Parkinson disease. Show reference: https://www.nature.com/articles/s41586-025-08845-y
In the first part of this two-part series, Dr. Jeff Ratliff and Dr. Claire Henchcliffe discuss the important lessons learned from these results. Show reference: https://www.nature.com/articles/s41586-025-08845-y
Dr. Jason Crowell and Dr. Brian E. Emmert discuss the concept behind the survey and the surprising findings from the survey results. Show reference: https://www.neurology.org/doi/10.1212/NE9.0000000000200221
In part two of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the effect of temperature and precipitation on the incidence of West Nile Neuroinvasive Disease. Show reference: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(24)00318-1/fulltext
In part one of this ten-part series, Dr. Paul Crane and Dr. Prashanth Ramachandran discuss the new global cryptococcal meningitis guidelines. Show reference: https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(23)00731-4/abstract
In the July episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss the role science plays in what the AAN does. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight
In part one of this three-part series, Dr. Justin Abbatemarco and Drs. John Chen and Smathorn Thakolwiboon discuss the outcomes following plasma exchange in MOGAD and explore how the findings from this study can inform patient care.
Dr. Dan Ackerman and Drs. Luuk Dekker and Jasper D. Daems discuss the analysis of various aLVO stroke detection scales to determine which one is the most useful for prehospital triage. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213570
In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Mary Lasker.
In the final episode of this three-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the PINGS-2 Trial, which was presented at the 2025 European Stroke Organization Conference. Show reference: https://eso-stroke.org/wp-content/uploads/Curtain-Raiser-2-1.pdf
In part two of this three-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the OPTIMISTmain Trial, which was presented at the 2025 European Stroke Organization Conference. Show reference: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(25)00549-5/abstract
In part one of this three-part series, Dr. Andy Southerland and Dr. Seemant Chaturvedi discuss the BRIDGE-TNK Trial, which was presented at the 2025 European Stroke Organization Conference. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2503867
Dr. Elizabeth Coon and Dr. Peter Novak discuss how central sensitization plays a role in the autonomic symptoms-sings dichotomy and the importance of addressing both conditions for optimal treatment. Show references: https://www.neurology.org/doi/10.1212/CPJ.0000000000200463
In this episode of the Neurology Minute, Dr. Alison Christy delves into another women's history minute to discuss Jean Holowach-Thurston.
In the second installment of this two-part series, Dr. Jeff Ratliff and Dr. Brin E. Freund discuss clinical guidance for managing patients who may experience neurotoxicity from CAR T-cell, with a specific focus on seizure risk. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213535
In the June episode of the President's Spotlight, Dr. Jason Crowell and Dr. Natalia Rost discuss advocacy opportunities. Show reference: https://www.aan.com/about-the-aan/presidents-spotlight
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Brin E. Freund discuss the incidence of acute symptomatic seizures during CAR T-cell therapy. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213535
Dr. Halley Alexander and Dr. Serena Yin discuss the effectiveness of an electronic medical record best practice alert in preventing iatrogenic interventions for patients with a diagnosis of PNES. Show references: https://www.neurology.org/doi/10.1212/CPJ.0000000000200457
In the first episode of this new series, Dr. Andy Southerland discusses the June updates from the AAN's Capitol Hill Report (CHR). This month's CHR update includes a member story from Dr. José Posas. Stay updated with what's happening on the hill by visiting aan.com/chr. Learn how you can get involved with AAN advocacy.
Dr. Aaron Zelikovich discusses a phase 3 trial that looked at the use of inebilizumab in generalized myasthenia gravis. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2501561
In the final installment of this three-part series, Dr. Elizabeth Zollos discusses another important diagnostic tool, visually evoked potentials or VEP.
Dr. Halley Alexander and Dr. Samuel W. Terman discuss patients' perceived seizure risk, seizure risk tolerance, and risk counseling techniques. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200475
Dr. Katie Krulisky and Dr. Leah Blank discuss the impact of outpatient follow-up on readmission rates for older adults with epilepsy or seizures. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000213638
In the final part of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss his team's findings on the treatment approach presented in this paper. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397
In part two of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss how patients with amyloid-beta–related angiitis present. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397
In the concluding segment of this series, Dr. Halley Alexander and Dr. Coral M. Stredny delve into the essential components of seizure action plans and identify the individuals who should have one. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200449
In part one of this two-part series, Dr. Halley Alexander and Dr. Coral M. Stredny discuss the importance of seizure action plans and how this might translate into our clinical care. Show reference: https://www.neurology.org/doi/10.1212/CPJ.0000000000200449
Dr. Nadia Khalil and Dr. Jean Bouchart discuss the diagnostic approach to intracerebral hemorrhage, the causes of cerebral small vessel disease, and the interpretation of biomolecular tests. Show reference: https://www.neurology.org/doi/10.1212/WNL.0000000000209796
In the final episode of this three-part series, Dr. Jodie Roberts and Dr. Urs Fisch discuss functional/dissociative seizures and driving risk. Learn more about the Neurology® Practice Current section and fill out the current survey on functional/dissociative seizures and driving.
In part two of this three-part series, Dr. Jodie Roberts and Dr. Barbara A. Dworetzky discuss how often seizure-like or seizure-resembling episodes lead to a diagnosis of functional neurologic disorder. Learn more about the Neurology® Practice Current section and fill out the current survey on functional/dissociative seizures and driving.
In part one of this three-part series, Dr. Jodie Roberts and Dr. Barbara A. Dworetzky discuss the term "functional seizures" and clarify the terminology. Learn more about the Neurology® Practice Current section and fill out the current survey on functional/dissociative seizures and driving.
In part one of this three-part series, Dr. Justin Abbatemarco and Dr. Sumanth Reddy discuss small vessel primary CNS vasculitis. Show reference: https://www.neurology.org/doi/10.1212/NXI.0000000000200397
Dr. Greg Cooper and Dr. David A. Wolk discuss limbic predominant age-related TDP-43 encephalopathy (LATE), covering its clinical features, diagnostic criteria, and more. Show reference: https://alz-journals.onlinelibrary.wiley.com/doi/full/10.1002/alz.14202
In the second installment of this three-part series, Dr. Elizabeth Zollos discusses the use of magnetic resonance imaging (MRI) in multiple sclerosis diagnosis.
© 2020-2025 Ivy Podcast Discovery LLC
